UK Companies House feature
Q SQUARED SOLUTIONS HOLDINGS LIMITED
Profile
- Company number
- 09636793
- Status
- Active
- Incorporation
- 2015-06-12
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 86900
- Hubs
- UK Healthcare
Accounts
Pending extraction
No iXBRL extracted yet for this company.
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Auditor
- Forvis Mazars LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on a going concern basis. The company meets its day-to-day working capital requirements through its cash reserves and borrowings. The Company should be able to operate within the level of its current cash resources and borrowings. After making enquiries, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.”
Subsidiaries
- Clinical Lab Minority Shareholder Limited · 100% held · United Kingdom · Holding company
- Q Squared Solutions China (Quest) Limited · 100% held · United Kingdom · Dormant
- Q Squared Solutions Proprietary Limited · 100% held · South Africa · Lab
- Q Squared Solutions China Limited · 100% held · United Kingdom · Dormant
- Q Squared Solutions Holding BV · 100% held · Netherlands · Dormant
- Q Squared Solutions KK · 100% held · Japan · Lab
- Q Squared Solutions Pte Ltd · 100% held · Singapore · Lab
- Q Squared Solutions Limited · 100% held · United Kingdom · Lab
- Q Squared Solutions S.A. · 90% held · Argentina · Lab
- Q Squared Solutions (Quest) Limited · 100% held · United Kingdom · Dormant
- Q Squared Solutions BV · 100% held · Netherlands · Dormant
- Q Squared Solutions (Beijing) Co.Limited · 100% held · China · Lab
- Q Squared Solutions S.A. · 10% held · Argentina · Lab
Significant events
- “On 1 April 2021, IQVIA Biotech Ltd, a fellow group undertaking acquired the 40% minority share of Q Squared Solutions Holdings Limited from Quest Diagnostics Subsidiary Holdings Ltd for £253,520,333, resulting in 100% ownership by IQVIA.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
5 active · 20 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| WILLIFORD, John | Secretary | 2020-01-01 | — | — |
| JTC (UK) LIMITED | Corporate Secretary | 2023-06-29 | — | — |
| LOWEY, Elaine | Director | 2024-07-31 | Oct 1978 | British |
| THORNLEY, Simon Carwyn | Director | 2022-08-25 | Feb 1972 | British |
| TURLAND, Kevin John | Director | 2022-08-25 | Mar 1969 | British |
Show 20 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BROOKS, Marc | Secretary | 2015-07-01 | 2017-02-08 |
| ESTRADA, Santiago | Secretary | 2017-02-09 | 2019-12-31 |
| FOVARGUE, Helen | Secretary | 2017-02-09 | 2019-11-01 |
| BROWN, Tony | Director | 2022-08-25 | 2024-07-31 |
| BROWN STAFFORD, Paula | Director | 2015-07-01 | 2016-01-01 |
| BRUEHLMAN, Ronald Earl | Director | 2017-02-09 | 2022-08-25 |
| FONSECA, Lidia | Director | 2017-02-09 | 2019-02-13 |
| FUNK, Randy Lee | Director | 2019-02-11 | 2021-04-01 |
| GORDON, Kevin Karl | Director | 2015-07-01 | 2016-10-03 |
| GUINAN, Mark James | Director | 2018-05-17 | 2021-04-01 |
| HAYDON, John Bradley | Director | 2015-07-01 | 2018-05-17 |
| LORENZ, Rene | Director | 2016-10-04 | 2022-08-25 |
| MACDONALD, Alasdair | Director | 2015-06-12 | 2015-07-01 |
| NORMAN, Jay | Director | 2015-07-01 | 2017-02-08 |
| PANAGOS, Constantinos | Director | 2017-02-09 | 2018-09-10 |
| RALPHSON, Neil | Director | 2015-07-01 | 2018-05-17 |
| SHORTEN, Dermot Victor | Director | 2015-07-01 | 2017-02-08 |
| SPAEDER, Jeffrey | Director | 2020-06-05 | 2022-08-25 |
| STEWART, Wendy | Director | 2018-05-17 | 2022-08-25 |
| VERST, Cynthia | Director | 2018-09-10 | 2020-06-05 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Iqvia Biotech Ltd. | Corporate entity | Shares 25–50%, Voting 25–50% | 2021-04-01 | Active |
| Quest Diagnostics Subsidiary Holdings Ltd | Corporate entity | Shares 25–50%, Voting 25–50% | 2016-04-06 | Ceased 2021-04-01 |
| Iqvia Ltd. | Legal person | Shares 50–75% | 2016-04-06 | Ceased 2016-04-06 |
| Iqvia Ltd. | Corporate entity | Shares 50–75%, Voting 50–75%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 104 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-07-08 | AA | accounts | accounts with accounts type full |
| 2025-06-20 | CS01 | confirmation-statement | confirmation statement with updates |
| 2024-12-10 | SH01 | capital | capital allotment shares |
| 2024-12-09 | SH01 | capital | capital allotment shares |
| 2024-08-02 | TM01 | officers | termination director company with name termination date |
| 2024-08-02 | AP01 | officers | appoint person director company with name date |
| 2024-07-10 | AA | accounts | accounts with accounts type full |
| 2024-06-13 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-11-06 | CH01 | officers | change person director company with change date |
| 2023-10-09 | AD02 | address | change sail address company with old address new address |
| 2023-10-06 | AP04 | officers | appoint corporate secretary company with name date |
| 2023-07-15 | AA | accounts | accounts with accounts type full |
| 2023-06-13 | CS01 | confirmation-statement | confirmation statement with updates |
| 2023-01-19 | AAMD | accounts | accounts amended with accounts type full |
| 2022-09-07 | AA | accounts | accounts with accounts type full |
| 2022-08-31 | TM01 | officers | termination director company with name termination date |
| 2022-08-31 | TM01 | officers | termination director company with name termination date |
| 2022-08-31 | TM01 | officers | termination director company with name termination date |
| 2022-08-31 | AP01 | officers | appoint person director company with name date |
| 2022-08-31 | TM01 | officers | termination director company with name termination date |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Credit score requires extracted accounts data.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory
Activity Score not yet computed for this company.